tci Part B Insider - 2004 Issue 3

Coverage: Electromagnetic Therapy Now Covered for Wound Healing

But CMS kicked the ball down the field on blood-derived productsIf your practice provides chemotherapy or wound therapy, some recent national coverage decisions from the Centers for Medicare & Medicaid Services could be important. In the past month or so, CMS has unveiled coverage decisions for the following issues: Autologous blood-derived products for chronic nonhealing wounds. CMS decided not to cover a platelet-derived wound-healing formula known as Procuren back in 1994, but since then a number of other products have come on the market and it's not clear if CMS covers them. In a December decision memo, CMS clarified...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.